Episode 83 with Dr. Jerry Wolinsky on composite clinical trial outcome measures
MS researchers have been looking to composite endpoints as more sensitive and meaningful measures of MS progression and disability for testing new drugs.
MS researchers have been looking to composite endpoints as more sensitive and meaningful measures of MS progression and disability for testing new drugs.
Clinical Research, Drug Development